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CHAPTER I 
 
 
INTRODUCTION 
 
Triclosan (2,4,4'-trichloro-2'-hydroxydiphenyl ether) is a hydrophobic antimicrobial agent 
frequently incorporated into household and personal care products for its biocidal properties. 
While it likely exerts multiple mechanisms of action, the compound has been shown to 
specifically inhibit enoyl ACP-reductase (FabI) (McMurry et al., 1998), an enzyme essential for 
fatty acid biosynthesis in bacteria.  It exhibits an extremely broad antibacterial spectrum against 
disparate bacterial pathogens with the notable exception of Pseudomonas aeruginosa (Champlin 
et al., 2005; Ellison et al., 2007; Ellison and Champlin, 2007).  This gram-negative organism is 
environmentally ubiquitous and a common opportunistic cause of nosocomial infections in 
chronically ill and immunocompromised patients.  P. aeruginosa is intrinsically resistant to 
extremely high concentrations of triclosan due to multiple mechanisms (Hoang and Schweizer, 
1999; Heath and Rock, 2000; Mima et al., 2007)  including exclusion by an outer membrane 
which is impermeable to nonpolar compounds (Champlin et al., 2005).  More recent work has 
revealed the transitory nature of P. aeruginosa sensitization to triclosan by the synergistic outer 
membrane permeabilizer compound 48/80 is likely due to a compensatory function of triclosan-
recognizing efflux pumps rather than obviation of a hydrophobic diffusion pathway (Ellison et 
al., 2007).  
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 Previous work in this laboratory has shown the opportunistic pathogen Pasteurella 
multocida to be highly susceptible to triclosan despite its ultrastructurally typical gram-negative 
cell envelope (Champlin et al., 2005).  Subsequent research (Ellison and Champlin, 2007) 
determined such growth inhibition to be either bacteriostatic or bactericidal in a dose-dependent 
manner.  Enhanced uptake of the hydrophobic probe 1-N-phenylnaphthylamine relative to the 
refractory control organisms P. aeruginosa and Escherichia coli suggested the presence of 
regions of surface-exposed phospholipid bilayer in the P. multocida outer membrane.  It was 
concluded that the extreme susceptibility of P. multocida to triclosan (Champlin et al., 2005) as 
well as other nonpolar antimicrobial agents (Hart and Champlin, 1988) is due to the general 
inability of the outer membrane to exclude hydrophobic molecules.  Low triclosan concentrations 
which inhibited growth of untreated P. multocida cultures were only effective for P. aeruginosa 
when rendered susceptible using outer membrane-permeabilizing concentrations of polymyxin B-
nonapeptide, compound 48/80, or ethylenediaminetetraacetate (Champlin et al., 2005). 
     Because it is both a highly efficacious and safe antiseptic, triclosan is widely 
incorporated into hospital health care products.  Protocols for surgical handwashing involving 
wash scrubs containing triclosan have been evaluated (Pereira et al., 1997), and studies have 
found personnel handwashes formulated with triclosan to be mild yet effective, making such 
products ideal for general and high-risk areas within the healthcare setting (Zafar et al., 1995; 
Jones et al., 2000).  A case study in which patient bathing solutions containing triclosan were 
used in a neonatal nursery to eradicate a methicillin-resistant Staphylococcus aureus outbreak was 
reported by Zafar et al. (1995).  Triclosan has also been incorporated into products such as gloves 
(Mixon, 1999), sutures (Edmiston et al., 2006; Fleck et al., 2007), and surgical drapes (Microtek 
Medical, Inc, 2002) to reduce the risk of post-surgical infection.   
It has become generally accepted that the frequent use of triclosan in health and personal 
care articles has resulted in its accumulation to demonstrable levels in human tissue fluids 
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(Allmyr et al., 2006) and the environment (Líndström et al., 2002; Bester, 2005; DeLorenzo et 
al., 2008) to include hospital effluent (Gómez et al., 2007).  One additional fate of triclosan has 
been postulated to be its catalytic methylation potentiated by microorganisms in various 
environments (Bester, 2005; DeLorenzo et al., 2008; Leiker et al., 2009).  As a result, methyl 
triclosan has concomitantly been reported to be increasingly present in disparate environmental 
systems such as surface waters (Líndström et al., 2002; Bester, 2005; DeLorenzo et al., 2008; 
Leiker et al., 2009) and sewage (Líndström et al., 2002; Bester, 2005; Farré, 2008), as well as 
biological systems (Leiker et al., 2009; Balmer et al., 2004).  Líndström et al. (2002) described 
the presence of triclosan in lakes and a river in Switzerland and reported that triclosan and its 
methyl derivative were only found in the lakes studied which had anthropogenic sources, while 
both were absent in a remote mountain lake.  This finding supports the notion that environmental 
triclosan accumulation is due to frequent incorporation into products for human use and that 
methyl triclosan results as consequence of biological modification.  Bester (2005) reported the 
presence of triclosan in surface waters was the result of sewage treatment plant effluent, and also 
suggested that environmental methyl triclosan is a result of microorganism-catalyzed triclosan 
transformation.  In an effort to determine the toxicity of triclosan in estuarine systems, DeLorenzo 
et al. (2008) examined adult shrimp in order to assess bioaccumulation.  After a 14-day exposure 
to triclosan, investigators observed the accumulation of methyl triclosan, thereby suggesting 
formation of this triclosan metabolite in the seawater environment.  Methyl triclosan was also 
found by Balmer et al. (2004) and Leiker et al. (2009) to be present in surface waters and to be 
accumulating in fish tissues.  Both DeLorenzo et al. (2008) and Leiker et al. (2009) have 
suggested based on their work that the consequences of the accumulation of environmental 
metabolites of triclosan warrant further research.    
The triclosan minimal inhibitory concentration for P. aeruginosa far exceeds its solubility 
in aqueous media (Champlin et al., 2005).  It was therefore necessary to determine the effect of 
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methylation on triclosan efficacy using susceptible organisms such as P. multocida for bioassay 
purposes.  Wild-type P. aeruginosa K799, mutant P. aeruginosa Z61 (a genetic variant 
possessing a permeable outer membrane phenotype) (Nikaido and Vaara, 1985; Zimmermann, 
1979), and outer membrane permeabilized wild-type P. aeruginosa PA01 were also examined in 
order to assess the possible involvement of outer membrane exclusion (Champlin et al., 2005) in 
the mechanism underlying the relationship between methyl triclosan and the gram-negative cell 
surface.
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CHAPTER II 
 
 
METHODOLOGY 
 
Bacterial Strains, Maintenance, and Cultivation 
P. multocida ATCC 11039, Serratia marcescens ATCC 8100, E. coli ATCC 25922, 
Salmonella typhimurium ATCC 14028, Burkholderia multivorans ATCC BAA-247, P. 
aeruginosa  Z61 (ATCC 35151), Bacilus subtilus ATCC 6633, and Staphylococcus aureus 
ATCC 25923 were purchased from the American Type Culture Collection (Manassas, VA).  P. 
multocida ATCC 11039/iso is a capsule-negative variant derived from P. multocida ATCC 11039 
(Champlin et al, 1999),  P. multocida P-1581 was obtained from the USDA National Animal 
Disease Center (Ames, IA), P. aeruginosa PA1211 was provided by Dr. A.M. Zelazny of the 
National Institute of Allergy and Infectious Diseases (NIH, Bethesda, MD), P. aeruginosa K799 
was provided by Dr. R.E.W. Hancock (University of British Columbia, Vancouver, Canada),  P. 
aeruginosa PA01 is maintained in this laboratory as a reference organism, and S. aureus T-5706 
was provided by Dr. Frank Austin (Mississippi State University College of Veterinary Medicine).  
All bacteria are maintained as cryopreserved stock cultures as described previously (Darnell et 
al., 1987) and cultivated on Mueller Hinton Agar (MHA; Difco Laboratories, Detroit, MI) plates 
for 18 h at 37°C to provide working culture sources for inocula.  Starter and test cultures were 
prepared using Mueller Hinton Broth (MHB; Difco Laboratories) or MHA and incubated at 37°C 
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under conditions described previously (Darnell et al., 1987; Champlin et al., 2005; Ellison et al., 
2007; Ellison and Champlin, 2007). 
 
Chemicals 
Ethanol (95% denatured alcohol; Fisherbrand, Pittsburgh, PA) was employed for control 
and triclosan solubilization purposes.  Stock solutions of triclosan (Irgasan DP 300; Ciba 
Specialty Chemicals Corp., High Point, NC) and methyl triclosan (Triclosan-methyl; Sigma-
Aldrich Chemical Co., St. Louis, MO) were prepared to desired concentrations in ethanol and 
stored tightly capped at 4ºC until needed.   
 
Disk Agar Diffusion Bioassay 
Triclosan is not soluble in aqueous media at concentrations greater than 32 µg/ml, a value 
far less than its minimal inhibitory concentration for P. aeruginosa (Champlin et al., 2005; 
Ellison et al., 2007).  Therefore, the effect of triclosan and methyl triclosan on the ability to 
initiate growth was determined using a modification of a standardized disk agar diffusion 
bioassay (Hart and Champlin, 1988).  Test cultures were obtained by inoculating culture tubes (18 
x 150 mm, Kimax) each containing 5.0 ml of MHB with stationary-phase starter culture cells to 
an initial optical density at 620 nm (OD620) of 0.025 (Spectronic 20 optical spectrophotometer; 
Thermo Electron Corp., Madison, WI) and incubating under standard conditions at 37°C with 
rotary aeration at 180 rpm (Excella E24 benchtop incubator shaker; New Brunswick Scientific 
Co., Inc, Edison, NJ) until an OD620 of 0.10 was reached.  Standard (100 x 15 mm) or large (150 
x 15 mm) MHA plates were seeded by aseptically transferring 150 or 250 µl, respectively, of 
appropriate test culture to the center of each plate.  A cotton swab saturated with sterile MHB was 
then used to spread inoculate each plate in a uniform manner.  Sterile paper disks (6.0-mm 
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diameter; Becton, Dickinson and Co., Sparks Glencoe, MD) were impregnated with different 
concentrations of triclosan or methyl triclosan dissolved in ethanol (95%) or ethanol (95%) alone 
(control), air-dried overnight under flowing sterile air, and aseptically placed on seeded agar 
plates.  Plates were placed at 4°C for one hour prior to incubation at 37°C for 18 h, after which 
zones of growth inhibition surrounding each disk were measured with the aid of electronic 
calipers. 
 
Turbidimetric Growth Kinetics Bioassay 
The effect of triclosan and methyl triclosan on total cell density growth kinetics was 
assessed turbidimetrically using a slight modification of the method described by Champlin et al., 
2005 and  Ellison and Champlin, 2007.  Stationary-phase cells from overnight starter cultures 
were employed to inoculate sterile MHB to an initial OD620 of 0.025 (Spectronic 20 optical 
spectrophotometer).  Test cultures were then prepared by dispensing 5.0-ml aliquots into each 
culture tube (18.0-mm diameter, Kimax) and immediately incubating.  Growth was assessed by 
monitoring OD620 at 30-minute intervals for 6.0 h.  Biocide treatments were added post-
inoculation at 1.5 h during early exponential phase by aseptically pipetting triclosan or methyl 
triclosan to final concentrations of 0.2 or 2.0 µg/ml.  OD620 measurements for each test culture 
were plotted against time on semi-logarithmic graph paper in order to visualize the effects of 
treatment on culture growth. 
 
P. aeruginosa Outer Membrane Permeabilization 
The ability of compound 48/80 to synergistically inhibit cultural growth in the presence 
of either triclosan or methyl triclosan by outer membrane permeabilization (Champlin et al., 
2005; Vaara, 1992) was evaluated using turbidimetric assessments of batch cultural growth 
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kinetics. A previously described protocol of (Champlin et al., 2005) with slight modifications as 
described above was employed to comprise a total cell density growth kinetics bioassay with the 
addition of compound 48/80 to the treatments at 1.5 h post-inoculation such that the final 
triclosan or methyl triclosan concentration was 2.0 µg/ml and the final compound 48/80 
concentration was 5.0 µg/ml in indicated test cultures.
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CHAPTER III 
 
 
FINDINGS 
 
Previous reports from this laboratory have revealed that P. multocida is markedly 
susceptible to the hydrophobic biocide triclosan (Champlin et al., 2005; Ellison and Champlin, 
2007), despite exhibiting typically gram-negative cell envelope ultrastructure.  In contrast, P. 
aeruginosa possesses intrinsic resistance to extremely high concentrations of the compound 
(Champlin et al., 2005; Hoang and Schweizer, 1999; Heath and Rock, 2000; Mima et al., 2007).  
The present study was undertaken to determine the influence of methylation on the antibacterial 
properties of triclosan in both triclosan susceptible and resistant organisms in order to better 
understand the environmental ramifications of the stable triclosan biotransformation product 
methyl triclosan.  It has been published in the Journal of Hospital Infection (Clayborn et al., 
2011). 
 In vitro Susceptibility to Triclosan and Methyl Triclosan 
A disk agar diffusion bioassay (Figure 1) was employed to determine the relative abilities 
of triclosan and methyl triclosan to inhibit the initiation of test organism growth under in vitro 
conditions.  All P. multocida strains examined were susceptible to triclosan at concentrations as 
low as 0.02 µg/disk regardless of host source or degree of capsulation (Figure 1, Table 1).  Two 
genetically-unrelated wild-type P. aeruginosa strains were resistant to triclosan at all 
concentrations employed.   B. multivorans and S. marcescens were least susceptible to triclosan 
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with growth only slightly inhibited by as much as 200 µg/disk, while E. coli and S. typhimurium 
exhibited intermediate levels of susceptibility.  Methyl triclosan failed to inhibit growth of any of 
the organisms examined at concentrations ranging from 0.02 to 200 µg/disk (Figure 1, Table 2). 
 Gram-positive bacteria possess no outer membrane and are highly susceptible to 
hydrophobic triclosan (Microtek-Medical, Inc, 2002).  To provide an assessment of a possible 
role for the outer membrane in the inability of methyl triclosan to inhibit growth in gram-negative 
bacteria, the disk agar diffusion bioassay was also employed to determine the susceptibility of 
three gram-positive organisms to either triclosan or methyl triclosan at concentrations of 0.02, 
0.2, and 2.0 µg/disk of each.   B. subtilus ATCC 6633, S. aureus T-5706, and S. aureus ATCC 
25923 were seen to be susceptible to triclosan in a dose-dependent manner, while methyl 
triclosan caused no inhibition of growth (Table 3) in a manner consistent with that seen for gram-
negative bacteria (Table 1, Table 2). 
Effect of Triclosan and Methyl Triclosan on Growth Kinetics 
To eliminate the possibility that variation in compound diffusibility in the disk agar 
diffusion bioassay was responsible for the disparate effects observed for triclosan and methyl 
triclosan, turbidimetric measurements of total cell densities of the treated P. multocida and P. 
aeruginosa type strains were employed.  As can be seen in Figure 2, P. multocida  ATCC 11039 
was susceptible to triclosan in a concentration-dependent manner, while P. aeruginosa  PA01 was 
resistant to triclosan at the same concentrations (0.2 and 2.0 µg/ml).  Neither organism was 
susceptible to methyl triclosan at either 0.2 or 2.0 µg/ml.  The apparent inability of methylated 
triclosan to inhibit bacterial growth (Table 2) was confirmed by these data. 
Outer Membrane Permeabilization of P. aeruginosa 
The role of outer membrane impermeability in triclosan resistance has been established 
previously by chemical permeabilization of intrinsically resistant P. aeruginosa cells (Champlin 
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et al., 2005; Ellison et al., 2007).  This conclusion is supported by the inherent susceptibility seen 
in intact P. multocida cells which possess an outer cell envelope intrinsically permeable to 
nonpolar molecules (Ellison and Champlin, 2007)  Another disk agar diffusion bioassay protocol 
in which a wild-type P. aeruginosa parental strain and a mutant exhibiting a permeable outer 
membrane phenotype was performed to investigate the potential dependency of methyl triclosan 
resistance on outer membrane permeability.  Data presented in Table 4 reveal that wild-type P. 
aeruginosa K799 was resistant to triclosan concentrations ranging over two orders of magnitude, 
while outer membrane permeability mutant P. aeruginosa Z61 was susceptible to triclosan in a 
concentration-dependent manner.  However, both wild-type and mutant strains were resistant to 
methyl triclosan at all concentrations employed. 
Similarly, using outer membrane permeabilizer compound 48/80 to chemically disrupt 
the P. aeruginosa PA01 outer cell envelope with regard to its impermeability properties for 
nonpolar antimicrobial agents failed to confer susceptibility to methyl triclosan at concentrations 
as high as 2.0 µg/ml (Figure 3).  This is in stark contrast with the demonstration that compound 
48/80 sensitized P. aeruginosa to the same concentration of triclosan in an initially bactericidal 
manner. 
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Table 1.  Susceptibility of  gram-negative test organisms to triclosan. 
 
Organism 
Inhibition zone diametera (mm) ± SD 
Controlb 0.02 µg 0.2 µg 2.0 µg 20 µg 200 µg 
P.  multocida ATCC 11039 0.0 ± 0.0 7.3 ± 1.1 20.2 ± 1.7 35.7 ± 3.2 46.0 ± 1.3 48.6 ± 1.2 
P.  multocida ATCC 11039/iso 0.0 ± 0.0 4.6 ± 0.7 12.3 ± 1.0 22.9 ± 1.7 32.5 ± 1.7 36.1 ± 1.9 
P.  multocida P-1581 0.0 ± 0.0 4.7 ± 1.0 18.9 ± 1.4 35.2 ± 1.7 46.5 ± 1.2 47.7 ± 1.3 
       
P.  aeruginosa PA01 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
P.  aeruginosa PA1211 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
       
S. marcescens ATCC 8100 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 1.1 ± 0.2 
E. coli ATCC 25922 0.0 ± 0.0 0.0 ± 0.0 4.0 ± 0.6 16.3 ± 0.6 25.3 ± 0.2 26.9 ± 0.4 
S. typhimurium ATCC 14028 0.0 ± 0.0 0.0 ± 0.0 2.3 ± 0.1 13.4 ± 0.3 21.2 ± 0.2 23.4 ± 0.4 
B. multivorans ATCC BAA-247 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.6 ± 0.2 2.1 ± 0.2 
 
aDiameter of growth inhibition zone minus disk diameter (6.0 mm); each value represents the mean of three to 
five independent determinations ± standard deviation. 
 bEthanol (95%) was used to facilitate triclosan solubilization, therefore control disks were prepared by 
impregnating with solvent alone and allowing to air dry prior to plate application. 
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Table 2.  Susceptibility of gram-negative test organisms to methyl triclosan. 
 
Organism 
Inhibition zone diametera (mm) ± SD 
Controlb 0.02 µg 0.2 µg 2.0 µg 20 µg 200 µg 
P.  multocida ATCC 11039 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
P.  multocida ATCC 11039/iso 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
P.  multocida P-1581 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
       
P.  aeruginosa PA01 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
P.  aeruginosa PA1211 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
       
S. marcescens ATCC 8100 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
E. coli ATCC 25922 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
S. typhimurium ATCC 14028 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
B. multivorans ATCC BAA-247 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
 
aSee Table 1. 
 bSee Table 1. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Representative disk agar diffusion bioassay for 
1, control (95% Ethanol);  2, 0.002 µg TCS;  3, 0.02 µg TCS;  4, 0.2 µg TCS;  5, 2.0 µg TCS;  6, 
20 µg TCS;  7, 200 µg TCS;  8, 0.002 µg MeTCS;  9, 0.02 µg MeTCS;  10, 0.2 
2.0 µg MeTCS; 12, 20 µg MeTCS;  13, 200 µg MeTCS.  (B) Susceptibility to TCS (
MeTCS ().  Diameter of growth inhibition zone minus disk diameter (6.0 mm); each value 
represents the mean of three to five independent determinations plus
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Table 3.  Susceptibility of gram-positive test organisms to triclosan or methyl triclosan. 
Organism 
Inhibition zone diametera (mm) ± SD 
Controlb  TCS (µg)  MeTCS (µg) 
 0.02 0.2 2.0  0.02 0.2 2.0 
B. subtilus ATCC     
 6633 0.0 ± 0.0  
0.0 ± 
0.0 
3.0 ± 
0.13 
13.2 ± 
0.21 
 
0.0 ± 
0.0 
0.0 ± 
0.0 
0.0 ± 
0.0 
S. aureus T-5701 0.0 ± 0.0  2.9 ± 0.16 
21.1 ± 
0.41 
36.3 ± 
0.91 
 
0.0 ± 
0.0 
0.0 ± 
0.0 
0.0 ± 
0.0 
S. aureus ATCC 
 25923 0.0 ± 0.0  
6.4 ± 
0.26 
22.4 ± 
0.14 
38.6 ± 
0.17 
 
0.0 ± 
0.0 
0.0 ± 
0.0 
0.0 ± 
0.0 
 
aSee Table 1; each value represents the mean of three independent determinations ± standard deviation. 
bSee Table 1. 
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Figure 2.  Total cell density growth kinetics of P. multocida ATCC 11039 (A) and P. aeruginosa 
PA01 (B) in the presence of either TCS or MeTCS.  Each value represents the mean of three to 
four independent determinations.  Symbols: , ethanol (0.4%, control); , TCS (0.2 µg/ml); , 
TCS (2.0 µg/ml); , MeTCS (0.2 µg/ml); , MeTCS (2.0 µg/ml). 
  
A B 
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Table 4.  Susceptibility of P. aeruginosa permeability variants to triclosan or methyl triclosan. 
Strain 
Inhibition zone diametera (mm) ± SD 
Controlb  TCS (µg)  MeTCS (µg) 
 2.0 20 200  2.0 20 200 
P. aeruginosa K799 
(wild-type) 0.0 ± 0.0  
0.0 ± 
0.0 
0.0 ± 
0.0 
0.0 ± 
0.0 
 
0.0 ± 
0.0 
0.0 ± 
0.0 
0.0 ± 
0.0 
P. aeruginosa Z61 
(permeable mutant) 0.0 ± 0.0  
0.0 ± 
0.0 
2.3 ± 
0.3 
5.0 ± 
0.1 
 
0.0 ± 
0.0 
0.0 ± 
0.0 
0.0 ± 
0.0 
 
aSee Table 1; each value represents the mean of three independent determinations ± standard deviation. 
bSee Table 1. 
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Figure 3.  Total cell density growth kinetics of outer membrane-permeabilized P. aeruginosa 
PA01 in the presence of either TCS or MeTCS.  Each value represents the mean of three 
independent determinations.  Symbols: , ethanol (0.4%, control); , compound 48/80 (5.0 
µg/ml); , TCS (2.0 µg/ml); , MeTCS (2.0 µg/ml); , compound 48/80 (5.0 µg/ml) plus TCS 
(2.0 µg/ml); , compound 48/80 (5.0 µg/ml) plus MeTCS (2.0 µg/ml).
Time (h)
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CHAPTER IV 
 
 
CONCLUSIONS 
 
These data support the notion that methylation of triclosan renders the compound unable 
to inhibit growth of disparate gram-negative and gram-positive bacterial pathogens exhibiting 
variant cell envelope permeability phenotypes in a manner independent of an intact outer 
membrane.  This finding is underscored by the fact P. multocida cell surface variant strains were 
seen to be resistant to methyl triclosan despite possessing an outer cell envelope that is 
remarkably permeable to nonpolar antimicrobial agents (Hart and Champlin, 1988).  That gram-
positive organisms exhibit no outer membrane, yet remain resistant to methyl triclosan validates 
this finding. 
  Meade et al.(2001) isolated two bacterial soil isolates which are able to employ triclosan 
as their sole carbon source in chemically-defined growth media, thereby explaining their ability to 
inactivate the biocide in both batch culture and impregnated plastic.  Biotransformation of 
triclosan by methylation in the environment represents a means by which the efficacy of the 
biocide would be decreased.  Obviation of the bactericidal properties of triclosan in such a 
manner might also be expected to mitigate potential selection of triclosan resistance due to 
alteration of the FabI enzyme (Heath et al., 1999) or the acquisition of adaptive cross-resistance 
to other antimicrobial compounds (Braoudaki and Hilton, 2004) as possible consequences of the 
presence of the compound in the human wastestream.  Moreover, it can also be concluded that 
biocide modification represents a potential mechanism contributing to the high levels of intrinsic 
triclosan resistance seen in P. aeruginosa. 
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 The value of the work summarized herein lies in the acquisition of a better understanding 
of biocide modification, namely microorganism-catalyzed methylation, and the ability to 
inactivate the growth-inhibitory properties of a compound known to exhibit broad spectrum 
antibacterial activity.  Implications of the study also include the notion that triclosan resistance in 
P. aeruginosa may in part be due to its ability to catalyze such modifications.  One important 
future extension of this work should involve an evaluation of the effects of triclosan on the 
morphology and ultrastructure of these test organisms.  A comparative analysis with methyl 
triclosan should be performed to determine if, despite its inability to inhibit growth, it confers 
morphological or ultrastructural changes to otherwise recalcitrant cells by virtue of its 
hydrophobic nature.  The demonstration that either or both compounds exert such effects would 
support the hypothesis that triclosan likely acts upon multiple mechanistic targets to include the 
cytoplasmic membrane and that this property is altered or obiviated by methylation of the 
compound. 
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